Table 1.

Description of subjects

SubjectNo. of HIV-1 RNA copies at entryELISAMedicationsaPhenotype of virusb
AC-01250,000NegativeZDV/3TC/INDR5
AC-024,850,000NegativeZDV/3TC/NFVR5
AC-0410,000,000NegativeZDV/3TC/NFVX4
AC-051,100,000WeakZDV/3TC/NFVR5
AC-068,180,000NegativeD4T/3TC/NFVR5
AC-1040,700WeakD4T/3TC/INDR5
AC-13730,000NegativeD4T/3TC/INDR5
AC-1495,000PositiveD4T/3TC/INDR5
AC-16337,000NegativeZDV/3TC/INDR5
  • a D4T, stavudine; 3TC, lamivudine; IND, indinavir, ZDV, zidovudine; NFV, nelfinavir.

  • b R5, CCR5 coreceptor usage; X4, CXCR4 coreceptor usage.